Vanessa Torrecillas

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Vanessa Torrecillas sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Vanessa Torrecillas: 1 sponsored US clinical trial, 1 recruiting.

Vanessa Torrecillas sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Velopharyngeal Insufficiency, with 1 trials.

Mid-pack sponsor footprint

Vanessa Torrecillas is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study

NCT07264036

Therapeutic Areas

Velopharyngeal Insufficiency 1
Speech Disorder 1
Dysphagia 1
Survivorship 1
Head and Neck Cancer 1

What is open in the Vanessa Torrecillas pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Velopharyngeal Insufficiency (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanessa Torrecillas: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Vanessa Torrecillas sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Vanessa Torrecillas1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Vanessa Torrecillas sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanessa Torrecillas sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Vanessa Torrecillas page

1 registered trials is a research-attention snapshot, not an endorsement of Vanessa Torrecillas or any single study.

  • 1 of Vanessa Torrecillas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Velopharyngeal Insufficiency is the condition Vanessa Torrecillas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Velopharyngeal Insufficiency trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vanessa Torrecillas pipeline card: 1 registered trials from official public datasets.Report a data error.